Rigel Pharmaceuticals
RIGL
RIGL
121 hedge funds and large institutions have $316M invested in Rigel Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 43 increasing their positions, 42 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% more funds holding
Funds holding: 120 → 121 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
121
Holding in Top 10
1
Calls
$3.05M
Puts
$1.07M
Top Buyers
| 1 | +$8.78M | |
| 2 | +$6.08M | |
| 3 | +$4.24M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$2.8M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$2.66M |
Top Sellers
| 1 | -$5.53M | |
| 2 | -$5.2M | |
| 3 | -$1.97M | |
| 4 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$1.89M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.83M |